Taiwanese researchers have found that combining an existing immunosuppressant drug with the COVID-19 medication remdesivir could suppress the ability of the virus to replicate, and thus could be a possible new treatment for the disease.
Lee Shiow-ju (李秀珠), an investigator with the Institute of Biotechnology and Pharmaceutical Research at the National Health Research Institutes, said remdesivir was once seen as a promising cure for COVID-19, but it never delivered on that promise.
Taiwanese doctors currently only use remdesivir to treat hospitalized COVID-19 patients in need of oxygen therapy and patients put on non-invasive ventilation, Lee said.
Photo: Reuters
Meanwhile, researchers in Taiwan have been trying to take advantage of existing drugs for their known safety profiles to expedite the discovery of effective and safe COVID-19 treatments.
After screening 230 prescription drugs covered by the National Health Insurance System, Lee said her team found that cyclosporine, an immunosuppressant widely used to prevent organ transplant rejection, could significantly reduce infection by coronaviruses.
Cyclosporine suppresses the activity of the immune system by inhibiting the activity and growth of T cells and the production of interleukin-6 (IL-6), a substance in the body that causes inflammation, Lee said.
In particular, IL-6 has been seen as an inflammatory marker for severe COVID-19 infections through its production of cytokines — small proteins that control the activity of other immune system cells.
A sudden increase in cytokines, known as a cytokine storm, can lead to serious inflammatory syndromes, and it has been associated with severe cases of COVID-19. Cyclosporine inhibits the production of those cytokines.
Cyclosporine has been on the market for years, making it highly accessible locally without the need to import drugs from overseas, Lee said.
Moreover, her team has found in simulations using cell lines (cells that are grown and then used to test candidate drugs) that the combination of cyclosporine and remdesivir are more effective in inhibiting coronaviruses from replicating than when the drugs are used separately.
The finding suggests that the combination of the two drugs merits further study as a possible treatment for COVID-19, she said.
However, follow-up clinical trials need to be conducted to prove the initial findings, Lee said.
FUKUOKA SITUATION: Japanese media reported that the pathogen is expected to be identified by the summer, while the CDC downplayed the idea that it was hMPV A “mysterious cold-like illness” reported in Japan’s Fukuoka Prefecture does not seem to be a new disease, but Japanese authorities have been asked about the situation, the Centers for Disease Control (CDC) said yesterday. The Fukuoka Prefectural Medical Association on Wednesday told a news conference that a “mystery cold” that has become a hot topic on social media is “highly likely to be caused by some kind of viral infection,” Japan’s KBC News reported. “Many people are experiencing symptoms starting with a sore throat, followed by a runny nose, phlegm and a severe cough,” KBC News reported, citing association officials. Health authorities are
Nvidia Corp CEO Jensen Huang (黃仁勳) arrived in Taiwan yesterday ahead of upcoming AI and technology events, saying he plans to meet with clients and Taiwan Semiconductor Manufacturing Co Chairman C.C. Wei (魏哲家) during his visit. After landing at Taipei Songshan Airport, Huang posed for photos with fans and handed out Yakult drinks to reporters and supporters waiting at the scene, saying he has “a lot to do” during the trip. Asked about reports that Nvidia’s planned headquarters site in Taipei’s Beitou Shilin Technology Park could break ground on May 27, Huang said that if the company holds an event, he would
Carrefour Taiwan is to begin using a new name from the start of July, but it cannot divulge the name until then, the chairman of the supermarket chain's parent company said today. President Chain Store Co chairman Lo Chih-hsien (羅智先) was asked by reporters after a shareholders' meeting to confirm whether the company has settled on a new name for the supermarket brand. In March, the government-registered name of two Carrefour Taiwan branches was quietly changed to "Le Chia Kang" (樂家康) in Chinese, raising speculation that has been selected as the name. Lo said that because of local regulations and contractual obligations, the
The Philippines would likely be involved in any conflict over Taiwan due to its proximity to the democracy claimed by China, President Ferdinand Marcos Jr said, reiterating a stance that risks angering Beijing. “In the Philippines, we do not have a choice because Taiwan is so close to the Philippines and we have almost 200,000 Filipino nationals living and working in Taiwan,” Marcos said in an interview with Japanese media in Manila on Monday. The Philippine leader’s comments come ahead of a state visit to Japan next week, where he is to meet with Japanese Prime Minister Sanae Takaichi to discuss security
RSS